Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goodscend is a China-based health and pharmaceutical technology company focused on the research, production, and commercialization of nutraceutical and health-related ingredients rather than a traditional therapeutic drug pipeline. The company is best known as a producer of synthetic vitamin K2 in both MK-4 and MK-7 forms and also markets vitamin K1 and nervonic acid, along with related finished dietary supplement and health food products. Its business appears to combine organic synthesis, ingredient manufacturing, formulation, and export-oriented commercial supply. Based in Shantou, Guangdong, the company operates production and R&D facilities and positions itself as a large-scale Chinese manufacturer of vitamin K2 raw materials and finished products. For biotech diligence purposes, it should be classified as a commercial health-ingredient and nutraceutical manufacturer, not a clinical-stage biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goodscend.